Vaccine manufacturer Biological E. Ltd on Monday announced the acquisition of Akorn India Ltd, a subsidiary of US-based Akorn Inc, for an undisclosed fee, providing a boost to the Hyderabad-based company’s manufacturing capacity as it prepares to mass produce two vaccine candidates, including that of Johnson & Johnson.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
